Cargando…

A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression

Purine nucleotides and nucleosides are involved in various human physiological and pathological mechanisms. The pathological deregulation of purinergic signaling contributes to various chronic respiratory diseases. Among the adenosine receptors, A2B has the lowest affinity such that it was long cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Effendi, Wiwin Is, Nagano, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002355/
https://www.ncbi.nlm.nih.gov/pubmed/36901855
http://dx.doi.org/10.3390/ijms24054428
_version_ 1784904370080448512
author Effendi, Wiwin Is
Nagano, Tatsuya
author_facet Effendi, Wiwin Is
Nagano, Tatsuya
author_sort Effendi, Wiwin Is
collection PubMed
description Purine nucleotides and nucleosides are involved in various human physiological and pathological mechanisms. The pathological deregulation of purinergic signaling contributes to various chronic respiratory diseases. Among the adenosine receptors, A2B has the lowest affinity such that it was long considered to have little pathophysiological significance. Many studies suggest that A2BAR plays protective roles during the early stage of acute inflammation. However, increased adenosine levels during chronic epithelial injury and inflammation might activate A2BAR, resulting in cellular effects relevant to the progression of pulmonary fibrosis.
format Online
Article
Text
id pubmed-10002355
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100023552023-03-11 A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression Effendi, Wiwin Is Nagano, Tatsuya Int J Mol Sci Review Purine nucleotides and nucleosides are involved in various human physiological and pathological mechanisms. The pathological deregulation of purinergic signaling contributes to various chronic respiratory diseases. Among the adenosine receptors, A2B has the lowest affinity such that it was long considered to have little pathophysiological significance. Many studies suggest that A2BAR plays protective roles during the early stage of acute inflammation. However, increased adenosine levels during chronic epithelial injury and inflammation might activate A2BAR, resulting in cellular effects relevant to the progression of pulmonary fibrosis. MDPI 2023-02-23 /pmc/articles/PMC10002355/ /pubmed/36901855 http://dx.doi.org/10.3390/ijms24054428 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Effendi, Wiwin Is
Nagano, Tatsuya
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
title A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
title_full A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
title_fullStr A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
title_full_unstemmed A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
title_short A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression
title_sort a2b adenosine receptor in idiopathic pulmonary fibrosis: pursuing proper pit stop to interfere with disease progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002355/
https://www.ncbi.nlm.nih.gov/pubmed/36901855
http://dx.doi.org/10.3390/ijms24054428
work_keys_str_mv AT effendiwiwinis a2badenosinereceptorinidiopathicpulmonaryfibrosispursuingproperpitstoptointerferewithdiseaseprogression
AT naganotatsuya a2badenosinereceptorinidiopathicpulmonaryfibrosispursuingproperpitstoptointerferewithdiseaseprogression